Stay updated with breaking news from Sudo Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indiana's tech companies landed a combined $348.8 million in venture funding last quarter, which was the strongest first-quarter activity since recordkeeping began in 2015, TechPoint says.
Indiana's tech companies landed a combined $348.8 million in venture funding last quarter, which was the strongest first-quarter activity since recordkeeping began in 2015, TechPoint says.
In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.
For the first time in almost six years, Y Combinator is extensively outlining 20 new categories of startups they’re interested in seeing.
The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind.--(BUSINESS WIRE)--#TYK2--Sudo Biosciences (“Sudo”), a biophar...